Three Arch Partners Company Profile

21:32 EDT 21st September 2018 | BioPortfolio

Three Arch Partners was formed in 1993 to provide young companies with access to relevant clinical and business resources, as well as capital. Three Arch has helped create, build and fund more than fifty important new healthcare companies. These companies have often become the clinical and market leaders in their respective fields, and have generated strong returns. The fund focuses on opportunities in medical devices and healthcare services, and less frequently in biotechnology.
Since inception, Three Arch has focused on identifying and creating new healthcare companies in markets with significant unmet clinical or infrastructure needs. The general partners do not wait for ideas to come to them, but actively create and source technology and management. As often, the fund assists physicians and inventors in establishing companies. Our involvement may include securing capital, assembling management, technical, and regulatory teams, and providing interim operational support.


3200 Alpine Road
Portola Valley
United States of America


Phone: (650) 529-8000
Fax: (650) 529-8039

News Articles [250 Associated News Articles listed on BioPortfolio]

Arch Coal Rewards Eight High School Graduates with Annual Scholarships

The Arch Coal Scholars Program is open to children of eligible employees of Arch Coal and its subsidiaries. Recipients are selected based on academic record, Read more...

Arch’s Bob Nelsen on Big Biotech and Why Pharma Should Be Very Afraid

Arch Venture Partners co-founder and managing director Bob Nelsen is widely regarded as one of the most astute and successful life science investors and company builders in the game. The list of his p...

Arch Biopartners to Seek Regulatory Guidance From the U.S FDA for AB569

ARch Biopartners (TSXV:ARCH) has announced it will seek regulatory guidance from the US Food and Drug Administration in a pre investigational new drug application meeting for AB569, its drug candidate...

Arch Biopartners Announces Listing on OTCQB Exchange

Arch Biopartners (TSX Venture:ARCH) (OTCQB:ACHFF) a portfolio-based biotechnology company, announced that the Company’s common shares have been approved to begin trading today on the OTCQB Venture M...

Beam launches, raises up to $87mm via Series A

Beam Therapeutics has launched with up to $87mm in Series A funding led by F-Prime Capital Partners and Arch Venture Partners.

With $87 Million in Hand, Beam Therapeutics Launches to Fight Disease with CRISPR Base Editing Te...

Beam Therapeutics, a new precision genetic medicines company, launched this morning with $87 million in a Series A funding round backed by F-Prime Capital Partners and ARCH Venture Partners.

Arch Therapeutics CEO looks ahead to positive results on AC5 gel

Arch Therapeutics (OTCMKTS:ARTH, OTCQB:ARTH) CEO Dr. Terry Norchie tells Proactive Investors the biotechnology company is developing a gel called AC5 that seals and protects leaking and bleeding tis...

Karuna completes $42 million financing round

Participants include ARCH Venture Partners, Wellcome Trust, PureTech Health, Steven Paul MD, and other undisclosed investors

Drugs and Medications [33 Associated Drugs and Medications listed on BioPortfolio]

Sweatblock [DC Alpine Partners, LLC DBA: Sweatblock]

SWEATBLOCK Clinical Strength Antiperspirant

Day cream mattifying hydrator [MOSAIC MARKETING PARTNERS LLC]


Ribavirin [Sandoz Inc]

These highlights do not include all the information needed to use RIBAVIRIN TABLETS safely and effectively. See full prescribing information for RIBAVIRIN TABLETS. Ribavirin Tablets, oralInitial U.S. ...

Ribavirin [Zydus Pharmaceuticals (USA) Inc.]

These highlights do not include all the information needed to use ribavirin safely and effectively. See full prescribing information for ribavirin. Initial U.S. Approval: 2002

Ribavirin [Cadila Healthcare Limited]

These highlights do not include all the information needed to use ribavirin safely and effectively. See full prescribing information for ribavirin. Initial U.S. Approval: 2002

PubMed Articles [392 Associated PubMed Articles listed on BioPortfolio]

Case Series of Aortic Arch Aneurysm in Patients with Bovine Arch Treated with Proximal Scalloped and Fenestrated Stent Graft.

The bovine arch is the most common variant of the aortic arch and occurs when the innominate artery shares a common origin with the left common carotid artery. We report an endovascular repair of aort...

Evaluation of Skeletal and Dental Effects of Lower Lingual Arches.

A lower lingual arch is usually recommended as a holding device to maintain arch length and to prevent mesial migration of the mandibular first molars. Despite its widespread use, comparatively little...

Arch Augmentation via Median Sternotomy for Coarctation of Aorta with Proximal Arch Hypoplasia.

Coarctation of the aorta can be associated with hypoplasia of the proximal transverse aortic arch. One approach to manage this condition is via left thoracotomy and extended end-to-end anastomosis wit...

Initial arch wires used in orthodontic treatment with fixed appliances.

Initial arch wires are the first arch wires to be inserted into the fixed appliance at the beginning of orthodontic treatment and are used mainly for the alignment of teeth by correcting crowding and ...

Is there a prospect for hybrid aortic arch surgery?

The surge of endovascular repair of aortic aneurysm in current modern aortic surgery practice has been the key for surgical management of elective cases of thoracic aortic aneurysms. This has paved wa...

Clinical Trials [411 Associated Clinical Trials listed on BioPortfolio]

Comparison of Arch Expansion Changes Between Passive Self-ligating and Conventional Brackets

The purpose of this randomized controlled clinical trial was to compare the transverse development of the arches and the incisor inclination comparing two different ligating systems (SL vs...

Aortic Arch Related Cerebral Hazard Trial (ARCH)

The ARCH is a controlled trial with a sequential design and with a prospective, randomized, open-label, blinded-endpoint (PROBE) methodology. The objective is to compare the efficacy and t...

Evaluation and Classification of Foot Medial Longitudinal Arch Height in Adults

The aim of the study is, to evaluate and classificate the medial longitudinal arch height in adult individuals. Aged between 18-40 years,350 adults who are voluntarily participate is going...

Partners Demonstration Project of PrEP and ART

The purpose of this protocol is to determine user preferences for antiretroviral therapy (ART) for HIV-1 infected partners and pre-exposure prophylaxis (PrEP) HIV-1 un-infected partners an...

Clinical Study for Evaluating the Safety and Efficacy of Total Endovascular Aortic Arch Repair

Aortic disease is a kind of cardiovascular diseases with very high mortality rate and high risk of surgical treatment. At present, the surgical and endovascular treatment for diseases in t...

Companies [937 Associated Companies listed on BioPortfolio]

Three Arch Partners

Three Arch Partners was formed in 1993 to provide young companies with access to relevant clinical and business resources, as well as capital. Three Arch has helped create, build and fund more than fi...


Privately held Endospan, headquartered in Herzlia (Tel Aviv), Israel, is a pioneer in the endovascular repair of Aortic Arch Disease including aneurysms and dissections. End...

Arch Grants

Arch Grants creates an entrepreneurial culture and infrastructure to build successful companies in St. Louis. The organization provides $50,000 equity-free grants and pro bono sup...

Kerberos Proximal Solutions, Inc.

Kerberos Proximal Solutions was a privately-held medical device company based in Cupertino, Calif. Founded in 2001, Kerberos was dedicated to developing innovative solutions to tr...

ARCH Clinical Research

ARCH Clinical Research provides pharmaceutical and biotechnology companies with high-quality clinical research services in Australia and New Zealand. In a time- and cost-efficient manner and according...

More Information about "Three Arch Partners" on BioPortfolio

We have published hundreds of Three Arch Partners news stories on BioPortfolio along with dozens of Three Arch Partners Clinical Trials and PubMed Articles about Three Arch Partners for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Three Arch Partners Companies in our database. You can also find out about relevant Three Arch Partners Drugs and Medications on this site too.

Quick Search


Relevant Topics

Health care (or healthcare) is the diagnosis, treatment, and prevention of disease, illness, injury, and other physical and mental impairments in humans. Health care is delivered by practitioners in medicine, chiropractic, dentistry, nursing, pharmacy, a...

Antibodies Antisense Assays Biochips Bioinformatics Biological Therapy Biomarkers Biomaterials Bioscience Cell Culture Cloning Cytokine Diagnostics Dna Extraction Dna Sequencing Dna Transform...

Corporate Database Quicklinks

Searches Linking to this Company Record